Target intelligence / Profile preview

Non-typeable Haemophilus influenzae bacterial antigens (NTHi antigens)

Target
NTHi antigens
Molecular classification
Bacterial surface protein, Adhesin, Porin, Lipoprotein
01

Overview

Non-typeable Haemophilus influenzae (NTHi) bacterial antigens are a collection of surface-exposed proteins and structures on NTHi strains, which are characterized by the absence of a polysaccharide capsule (Murphy et al., 2009, Journal of Clinical Investigation). These antigens, such as Protein D, Protein E, Protein F, and PilA, are essential for the bacterium's ability to adhere to and colonize the human respiratory epithelium (Pichichero, 2013, Expert Review of Vaccines). NTHi is a leading cause of acute otitis media in children and a major contributor to the pathogenesis and exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in adults (Wilkinson et al., 2017, European Respiratory Journal). Therapeutic development focuses on these antigens as vaccine candidates to induce protective immunity, specifically through the production of opsonizing antibodies that facilitate bacterial clearance (Langereis & de Jonge, 2015, Frontiers in Cellular and Infection Microbiology). Current clinical efforts, such as the development of multicomponent vaccines, aim to provide broad protection against diverse NTHi strains by targeting conserved surface proteins (GSK, 2024, Pipeline). These antigens are also being explored as targets for monoclonal antibodies to prevent colonization in high-risk populations (Su et al., 2020, Vaccines).

Other names
NTHi surface proteinsNon-encapsulated Haemophilus influenzae antigensNTHi adhesinsNTHi outer membrane proteins
02

Mechanism of action

Vaccine-mediated induction of opsonophagocytic antibodies and inhibition of bacterial adherence to host tissues.

03

Biological functions

Bacterial adhesionColonizationImmune evasionNutrient acquisitionBiofilm formation
04

Disease associations

Otitis mediaChronic obstructive pulmonary disease (COPD) exacerbationSinusitisPneumoniaInfection
05

Safety considerations

Antigenic variation among strainsPotential for strain replacementInflammatory response in the respiratory tract
06

Interacting drugs

Synflorix (Pneumococcal polysaccharide conjugate vaccine - contains Protein D)

3 more in the full profile.

07

Biomarkers

Anti-Protein D IgG antibody titersSerum bactericidal activity (SBA)Opsonophagocytic activity (OPA)

Beyond the preview

Go deeper on Non-typeable Haemophilus influenzae bacterial antigens (NTHi antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-typeable Haemophilus influenzae bacterial antigens (NTHi antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call